JP2009545613A5 - - Google Patents

Info

Publication number

JP2009545613A5

JP2009545613A5 JP2009523001A JP2009523001A JP2009545613A5 JP 2009545613 A5 JP2009545613 A5 JP 2009545613A5 JP 2009523001 A JP2009523001 A JP 2009523001A JP 2009523001 A JP2009523001 A JP 2009523001A JP 2009545613 A5 JP2009545613 A5 JP 2009545613A5

Authority

JP

Japan

Prior art keywords

propionamide

methylamino

fluoro

cyclohexyl

ethyl

Prior art date

2007-07-31

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 150000001875 compounds Chemical class 0.000 claims description 14
• 150000003839 salts Chemical class 0.000 claims description 9
• 239000003814 drug Substances 0.000 claims description 6
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
• 241000124008 Mammalia Species 0.000 claims description 4
• 239000008194 pharmaceutical composition Substances 0.000 claims description 3
• 230000002062 proliferating effect Effects 0.000 claims description 3
• 206010028980 Neoplasm Diseases 0.000 claims description 2
• 201000011510 cancer Diseases 0.000 claims description 2
• 238000004519 manufacturing process Methods 0.000 claims 6
• 229940080818 propionamide Drugs 0.000 claims 3
• XAQNBXGPXNSSIX-JBUDQFAYSA-N (2s)-n-[(1s)-1-cyclohexyl-2-[(2s)-2-[2-[(5-fluoropyridin-2-yl)amino]pyridin-4-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide Chemical compound C1([C@H](NC(=O)[C@H](C)NC)C(=O)N2[C@@H](CCC2)C=2C=C(NC=3N=CC(F)=CC=3)N=CC=2)CCCCC1 XAQNBXGPXNSSIX-JBUDQFAYSA-N 0.000 claims 2
• IWKCMACULCSOIW-CNVLFFCLSA-N (2s)-n-[(1s)-1-cyclohexyl-2-[ethyl-[(1s)-1-[5-(4-fluorobenzoyl)pyridin-3-yl]propyl]amino]-2-oxoethyl]-2-(methylamino)propanamide Chemical compound C1([C@H](NC(=O)[C@H](C)NC)C(=O)N(CC)[C@@H](CC)C=2C=C(C=NC=2)C(=O)C=2C=CC(F)=CC=2)CCCCC1 IWKCMACULCSOIW-CNVLFFCLSA-N 0.000 claims 2
• URMBYRAVRFKEMV-HYVJGQCMSA-N (2s)-n-[(2s)-1-[(2s)-2-[2-(4-fluoro-n-methylanilino)pyridin-4-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-2-(methylamino)propanamide Chemical compound CN[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1=CC=NC(N(C)C=2C=CC(F)=CC=2)=C1 URMBYRAVRFKEMV-HYVJGQCMSA-N 0.000 claims 2
• QDKWLJJOYIFEBS-UHFFFAOYSA-N 1-fluoro-4-$l^{1}-oxidanylbenzene Chemical group [O]C1=CC=C(F)C=C1 QDKWLJJOYIFEBS-UHFFFAOYSA-N 0.000 claims 2
• -1 4-fluoro-benzoyl Chemical group 0.000 claims 2
• 230000010261 cell growth Effects 0.000 claims 2
• KRRMBDSQBHVVSC-WDNCENIBSA-N (2s)-n-[(1s)-1-cyclohexyl-2-[(2s)-2-[2-(4-fluorobenzoyl)pyridin-4-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide Chemical compound C1([C@H](NC(=O)[C@H](C)NC)C(=O)N2[C@@H](CCC2)C=2C=C(N=CC=2)C(=O)C=2C=CC(F)=CC=2)CCCCC1 KRRMBDSQBHVVSC-WDNCENIBSA-N 0.000 claims 1
• GLYVRVIAICILAB-WYRQLCSISA-N (2s)-n-[(1s)-1-cyclohexyl-2-[(2s)-2-[2-(4-fluorophenoxy)pyridin-4-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide Chemical compound C1([C@H](NC(=O)[C@H](C)NC)C(=O)N2[C@@H](CCC2)C=2C=C(OC=3C=CC(F)=CC=3)N=CC=2)CCCCC1 GLYVRVIAICILAB-WYRQLCSISA-N 0.000 claims 1
• ZFAVFDQDUSXJIZ-WYRQLCSISA-N (2s)-n-[(1s)-1-cyclohexyl-2-[(2s)-2-[3-fluoro-2-(4-fluoro-n-methylanilino)pyridin-4-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide Chemical compound C1([C@H](NC(=O)[C@H](C)NC)C(=O)N2[C@@H](CCC2)C=2C(=C(N(C)C=3C=CC(F)=CC=3)N=CC=2)F)CCCCC1 ZFAVFDQDUSXJIZ-WYRQLCSISA-N 0.000 claims 1
• NFXXQKYLVUZHNH-OWSXEPHWSA-N (2s)-n-[(1s)-1-cyclohexyl-2-[(2s)-2-[3-fluoro-2-(4-fluorobenzoyl)pyridin-4-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide Chemical compound C1([C@H](NC(=O)[C@H](C)NC)C(=O)N2[C@@H](CCC2)C=2C(=C(C(=O)C=3C=CC(F)=CC=3)N=CC=2)F)CCCCC1 NFXXQKYLVUZHNH-OWSXEPHWSA-N 0.000 claims 1
• UAIWGTYMOQVDRN-DPSWKAHMSA-N (2s)-n-[(1s)-1-cyclohexyl-2-[(2s)-2-[4-(1h-indole-2-carbonyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide Chemical compound C1([C@H](NC(=O)[C@H](C)NC)C(=O)N2[C@@H](CCC2)C=2SC=C(N=2)C(=O)C=2NC3=CC=CC=C3C=2)CCCCC1 UAIWGTYMOQVDRN-DPSWKAHMSA-N 0.000 claims 1
• UNVLMOGNSFKSCZ-RXYZOABWSA-N (2s)-n-[(1s)-1-cyclohexyl-2-[(2s)-2-[4-(2,4-difluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide Chemical compound C1([C@H](NC(=O)[C@H](C)NC)C(=O)N2[C@@H](CCC2)C=2SC=C(N=2)C(=O)C=2C(=CC(F)=CC=2)F)CCCCC1 UNVLMOGNSFKSCZ-RXYZOABWSA-N 0.000 claims 1
• UFPFGVNKHCLJJO-SSKFGXFMSA-N (2s)-n-[(1s)-1-cyclohexyl-2-[(2s)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide Chemical compound C1([C@H](NC(=O)[C@H](C)NC)C(=O)N2[C@@H](CCC2)C=2SC=C(N=2)C(=O)C=2C=CC(F)=CC=2)CCCCC1 UFPFGVNKHCLJJO-SSKFGXFMSA-N 0.000 claims 1
• LNPBUMISJDVJHC-YROCYRMSSA-N (2s)-n-[(1s)-1-cyclohexyl-2-[(2s)-2-[4-(4-fluorobenzoyl)-5-methyl-1,3-oxazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide Chemical compound C1([C@H](NC(=O)[C@H](C)NC)C(=O)N2[C@@H](CCC2)C=2OC(C)=C(C(=O)C=3C=CC(F)=CC=3)N=2)CCCCC1 LNPBUMISJDVJHC-YROCYRMSSA-N 0.000 claims 1
• UGFVRQRAWJKTLV-WDNCENIBSA-N (2s)-n-[(1s)-1-cyclohexyl-2-[(2s)-2-[4-(4-fluorobenzoyl)pyridin-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide Chemical compound C1([C@H](NC(=O)[C@H](C)NC)C(=O)N2[C@@H](CCC2)C=2N=CC=C(C=2)C(=O)C=2C=CC(F)=CC=2)CCCCC1 UGFVRQRAWJKTLV-WDNCENIBSA-N 0.000 claims 1
• RLZDXFUYFJFSIW-WDNCENIBSA-N (2s)-n-[(1s)-1-cyclohexyl-2-[(2s)-2-[4-(4-fluorophenoxy)pyridin-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide Chemical compound C1([C@H](NC(=O)[C@H](C)NC)C(=O)N2[C@@H](CCC2)C=2N=CC=C(OC=3C=CC(F)=CC=3)C=2)CCCCC1 RLZDXFUYFJFSIW-WDNCENIBSA-N 0.000 claims 1
• MBMIQHIDJXPXLW-SQOVJYTMSA-N (2s)-n-[(1s)-1-cyclohexyl-2-[(2s)-2-[5-fluoro-2-(4-fluoro-n-methylanilino)pyridin-4-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide Chemical compound C1([C@H](NC(=O)[C@H](C)NC)C(=O)N2[C@@H](CCC2)C=2C(=CN=C(C=2)N(C)C=2C=CC(F)=CC=2)F)CCCCC1 MBMIQHIDJXPXLW-SQOVJYTMSA-N 0.000 claims 1
• MIKXVUSNIXOIHA-HDBFHEOPSA-N (2s)-n-[(1s)-1-cyclohexyl-2-[(2s)-2-[6-(4-fluorobenzoyl)-2-methylpyrimidin-4-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide Chemical compound C1([C@H](NC(=O)[C@H](C)NC)C(=O)N2[C@@H](CCC2)C=2N=C(C)N=C(C=2)C(=O)C=2C=CC(F)=CC=2)CCCCC1 MIKXVUSNIXOIHA-HDBFHEOPSA-N 0.000 claims 1
• PTIKANXLOMQMEE-XPEQFSOGSA-N (2s)-n-[(1s)-1-cyclohexyl-2-[(2s)-2-[6-(4-fluorophenoxy)-2-methylpyrimidin-4-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide Chemical compound C1([C@H](NC(=O)[C@H](C)NC)C(=O)N2[C@@H](CCC2)C=2N=C(C)N=C(OC=3C=CC(F)=CC=3)C=2)CCCCC1 PTIKANXLOMQMEE-XPEQFSOGSA-N 0.000 claims 1
• WZVNGBMTDXJHTR-LQGLAIQGSA-N (2s)-n-[(1s)-1-cyclohexyl-2-oxo-2-[(2s)-2-(4-phenoxypyridin-2-yl)pyrrolidin-1-yl]ethyl]-2-(methylamino)propanamide Chemical compound C1([C@H](NC(=O)[C@H](C)NC)C(=O)N2[C@@H](CCC2)C=2N=CC=C(OC=3C=CC=CC=3)C=2)CCCCC1 WZVNGBMTDXJHTR-LQGLAIQGSA-N 0.000 claims 1
• 230000009702 cancer cell proliferation Effects 0.000 claims 1
• 230000004663 cell proliferation Effects 0.000 claims 1
• 239000003937 drug carrier Substances 0.000 claims 1
• 238000006243 chemical reaction Methods 0.000 description 3
• 201000010099 disease Diseases 0.000 description 3
• 238000000034 method Methods 0.000 description 3
• 125000006239 protecting group Chemical group 0.000 description 3
• 239000002253 acid Chemical class 0.000 description 2
• PZAOLVHWUGBISR-NSHDSACASA-N CC(C)(C)OC(N(CCC1)[C@@H]1c1nc(C(N(C)OC)=O)c[s]1)=O Chemical compound CC(C)(C)OC(N(CCC1)[C@@H]1c1nc(C(N(C)OC)=O)c[s]1)=O PZAOLVHWUGBISR-NSHDSACASA-N 0.000 description 1
• 101710156605 Diablo homolog, mitochondrial Proteins 0.000 description 1
• 150000001299 aldehydes Chemical class 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 150000002576 ketones Chemical class 0.000 description 1
• 125000004430 oxygen atom Chemical group O* 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 239000000376 reactant Substances 0.000 description 1
• 229910052717 sulfur Inorganic materials 0.000 description 1
• 125000004434 sulfur atom Chemical group 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1